The US adult obesity rate fell to 36.4 percent in 2026, down from a peak of 39.9 percent in 2022, according to a Gallup report, while the share of adults taking GLP-1 drugs for weight loss rose from 3…
AI could help detect fatty liver disease earlier by analyzing electronic health records, according to Jeffrey Lazarus, a professor at the CUNY Graduate School of Public Health and Health Policy. The c…
Stanford Medicine researchers have discovered a naturally occurring molecule, BRP, that suppresses appetite and reduces body weight like Ozempic but without nausea, constipation, or significant muscle…
Researchers at Stanford Medicine used artificial intelligence to identify BRP (BRINP2-related peptide), a naturally occurring molecule that reduced food intake and body weight in mice and pigs without…
Technology is increasingly being used to modify human biology and cognition rather than the external world, as seen in AI tools that reduce cognitive effort and GLP-1 drugs that suppress desire. This …
Researchers at the University of Pennsylvania analyzed over 400,000 Reddit posts from nearly 70,000 users and found that patients taking GLP-1 weight-loss drugs like Ozempic frequently reported unexpe…